Lysosomal system and neurotrophic support defects In Alzheimer's disease (AD), and Down's syndrome (DS) are accompanied by altered expression of endocytosis-related genes. Triplication of App in DS cells causes similar endocytic pathway dysfunction mediated by the B C-terminal APP fragment (liCTF), independent of A&. This endosomal phenotype is associated with retrograde neurotrophic support failure and degeneration of basal forebrain cholinergic neurons (BFCNs). We propose to identify specific genes and their proteins In an interrelated pathway that consists of APP/APP metabolites and endosomal signaling effectors that impinge upon AD pathology-related processes including endosomal-lysosomal trafficking, autophagy, neurotrophic signaling, and cell cycle reentry defects in vulnerable septohippocampal neurons. We will target genes and proteins that link the abnormal endosomal phenotype to neurodegeneration In vulnerable BFCNs and CAI neurons in relevant animal models and human brains, including both App-dependent and App-independent pathways.
In Aim 1 we will identify discrete expression changes related to APP/BCTF and neurotrophin signaling pathways in BFCNs In trisomic mice and following fimbria-fornix (FF) transections in wild type mice before and after exogenous NGF rescue.
In Aim 2 we will define key players in an aberrant signaling pathway leading from abnormal endosomal phenotype to neurodegeneration in vulnerable versus less vulnerable neurons within the septohippocampal circuit.
In Aim 3, we hypothesize that APP overexpression in FAD and DS is mediated through BCTF and involves a rab5-driven pathway to neurodegeneration. Using a novel rab5 mouse model, we will determine whether rab5 up regulation is necessary and sufficient to cause endosomal dysfunction and neurodegeneration, or whether APP/ISCTF signaling is also required. Genetic manipulations of APP, BCTF, and rab5 levels In mice, coupled with qPCR in vulnerable cells acquired by LCM and immunocytochemistry for cell death markers are predicted to identify gene changes associated with interrelated APP/BCTF- and rab5-inifiated signaling cascades, thus identifying new potential therapeutic targets within these key pathways that initiate neurodegeneration.

Public Health Relevance

We employ mouse models and human postmortem brains to assess changes in a circuit critical for learning, memory, and attention that degenerate in Alzheimer's disease (AD). We will evaluate Individual neuronal populations to understand molecular mechanisms that cause vulnerability by comparing degenerating neurons to those that are relatively spared to determine factors for AD drug discovery and treatment.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG017617-13
Application #
8572259
Study Section
Special Emphasis Panel (ZAG1-ZIJ-6)
Project Start
Project End
Budget Start
2013-09-01
Budget End
2014-08-31
Support Year
13
Fiscal Year
2013
Total Cost
$289,861
Indirect Cost
$110,113
Name
Nathan Kline Institute for Psychiatric Research
Department
Type
DUNS #
167204762
City
Orangeburg
State
NY
Country
United States
Zip Code
10962
Alldred, Melissa J; Lee, Sang Han; Petkova, Eva et al. (2015) Expression profile analysis of vulnerable CA1 pyramidal neurons in young-Middle-Aged Ts65Dn mice. J Comp Neurol 523:61-74
Alldred, Melissa J; Lee, Sang Han; Petkova, Eva et al. (2015) Expression profile analysis of hippocampal CA1 pyramidal neurons in aged Ts65Dn mice, a model of Down syndrome (DS) and Alzheimer's disease (AD). Brain Struct Funct 220:2983-96
Kelley, Christy M; Powers, Brian E; Velazquez, Ramon et al. (2014) Sex differences in the cholinergic basal forebrain in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease. Brain Pathol 24:33-44
Counts, Scott E; Alldred, Melissa J; Che, Shaoli et al. (2014) Synaptic gene dysregulation within hippocampal CA1 pyramidal neurons in mild cognitive impairment. Neuropharmacology 79:172-9
Yan, Jian; Ginsberg, Stephen D; Powers, Brian et al. (2014) Maternal choline supplementation programs greater activity of the phosphatidylethanolamine N-methyltransferase (PEMT) pathway in adult Ts65Dn trisomic mice. FASEB J 28:4312-23
Xue, Xue; Wang, Li-Rong; Sato, Yutaka et al. (2014) Single-walled carbon nanotubes alleviate autophagic/lysosomal defects in primary glia from a mouse model of Alzheimer's disease. Nano Lett 14:5110-7
Kaur, Gurjinder; Sharma, Ajay; Xu, Wenjin et al. (2014) Glutamatergic transmission aberration: a major cause of behavioral deficits in a murine model of Down's syndrome. J Neurosci 34:5099-106
Kelley, Christy M; Powers, Brian E; Velazquez, Ramon et al. (2014) Maternal choline supplementation differentially alters the basal forebrain cholinergic system of young-adult Ts65Dn and disomic mice. J Comp Neurol 522:1390-410
Wesson, Daniel W; Morales-Corraliza, Jose; Mazzella, Matthew J et al. (2013) Chronic anti-murine Aýý immunization preserves odor guided behaviors in an Alzheimer's ýý-amyloidosis model. Behav Brain Res 237:96-102
Nixon, Ralph A (2013) The role of autophagy in neurodegenerative disease. Nat Med 19:983-97

Showing the most recent 10 out of 105 publications